Zymergen researches, develops, and manufactures microbes for Fortune 500 companies. It develops molecules for agriculture, chemicals, materials, pharmaceuticals, electronics, personal care, and more applications. Zymergen’s platform integrates automation, machine learning, and genomics to navigate the genomic search space. It uses a technology platform to optimize strains in that improves economics; improves the existing production strains within existing manufacturing processes; and improves the correlation between the lab and commercial manufacturing. Moreover, Zymergen offers new product development, such as engineering any molecules from any microbes that improves the power of biology to develop novel products. Jed Dean, Joshua J. Hoffman, and Zachary Serber founded it in 2013, with its headquarters in Emeryville in California with an additional office in Seattle in Washington.
Some data provided by Crunchbase
EquityZen does not have an affiliation with, formal relationship with, or endorsement from Zymergen or any companies featured above.
This profile is based on publicly available information and is intended to be informative in nature.
EQUITYZEN and logo are trademarks of EquityZen Inc. Other trademarks are property of their respective owners.
To learn more about whether you're eligible, typical investment size, company valuation, and share price, request access here.